Genomic Health, Inc. (GHDX) - a whopping 40% of its float short - New FusionIQ Short Squeeze

Genomic Health, Inc. (GHDX) a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer scored a base breakout and a new FusionIQ Short Squeeze.  With a whopping 40.00 + % of its float short and a point and figure target of $ 32.50 GHDX shares offer investors solid upside potential over the int. term.

Did you also know that Fusion offers money management services? Take our complimentary risk profile at www.fusioninvest.com/riskprofiler or call us toll free at 1-888-661-2022 to set up a call with an advisor.

 


Comments
Leave a comment
Name
Email Address
URL
Remember personal info?
Comments
Blog Home
RSS Feed
Categories
Barron's
Breakouts/Breakdowns
ChartWatch
Company in the News
Earnings
Equity Timing Signals (Buy/Sell)
Index Study
Market Data
Media
New Highs
Sector Group Rankings
Short Squeeze Screen
Stock Analysis
Total Stocks Rankings
Archives
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007